GBA1 and Parkinson disease: Moreover, because of the importance of the ALP pathway for PD independent of GBA mutations, one could hypothesize that finding the biomarkers that allow us to predict the conversion of GBA carriers to PD may also allow us to reveal those who will develop sPD.